287 results on '"Kroeker, Karen I"'
Search Results
2. Impact of Disease Activity and Inflammatory Bowel Disease Subtype on Quality of Life in Preconception and Pregnant Patients
3. Transition Readiness in Youth with Inflammatory Bowel Disease
4. A Dedicated Pregnancy Clinic Improves Reproductive Knowledge in Inflammatory Bowel Disease
5. Multimodal intervention to improve the transition of patients with inflammatory bowel disease from pediatric to adult care: protocol for a randomized controlled trial
6. Gender Trends in Authorship of Gastroenterology Randomized Controlled Trial Literature.
7. Urine and Serum Metabolomic Profiles Differ by Disease Activity in Pregnant Women With Inflammatory Bowel Diseases
8. Concomitant 5-Aminosalicylate Therapy in Moderate-to-Severe Ulcerative Colitis Patients Escalated to Infliximab Is Not Beneficial
9. Outcomes in Patients with Inflammatory Bowel Disease Transitioning from Pediatric to Adult Care: A Scoping Review.
10. Perspectives of patients, parents, and health care providers on facilitators of and barriers to the transition from pediatric to adult care in inflammatory bowel disease: a qualitative descriptive study
11. Breastfeeding Patterns in Mothers with Inflammatory Bowel Disease: A Pilot Prospective Longitudinal Study
12. Effect of an Electronic Medical Record-Based Clinical Decision Support System on Adherence to Clinical Protocols: An Interrupted Time Series Study in Inflammatory Bowel Disease (Preprint)
13. Incidence and Prevalence of Primary Sclerosing Cholangitis: A Meta-analysis of Population-based Studies
14. An overview of clinical decision support systems: benefits, risks, and strategies for success
15. Incidence Rates for Surgery in Crohn’s Disease Have Decreased: A Population-based Time-trend Analysis
16. Crohn's disease outpatients treated with adalimumab have an earlier secondary loss of response and requirement for dose escalation compared to infliximab: A real life cohort study
17. Real-life Treatment Paradigms Show Infliximab Is Cost-effective for Management of Ulcerative Colitis
18. Elevated IL-6 and IL-22 in Early Pregnancy Are Associated with Worse Disease Course in Women with Inflammatory Bowel Disease
19. Anti-Inflammatory Diet Prevents Subclinical Colonic Inflammation and Alters Metabolomic Profile of Ulcerative Colitis Patients in Clinical Remission
20. Impact of Disease Activity and Inflammatory Bowel Disease Subtype on Quality of Life in Preconception and Pregnant Patients
21. A Distinctive Urinary Metabolomic Fingerprint Is Linked With Endoscopic Postoperative Disease Recurrence in Crohn’s Disease Patients
22. Within-Stool and Within-Day Sample Variability of Fecal Calprotectin in Patients With Inflammatory Bowel Disease: A Prospective Observational Study
23. Assessing the Transition Intervention Needs of Young Adults With Inflammatory Bowel Diseases
24. Healing of Tonsillar Crohn’s Disease With Infliximab
25. Declining Corticosteroid Use for Inflammatory Bowel Disease Across Alberta: A Population-Based Cohort Study
26. STRICTURE DILATION VIA BALLOON-ASSISTED ENDOSCOPY IN SMALL BOWEL CROHN'S DISEASE: INTRAPROCEDURAL OUTCOMES AND COMPARISON OF THE SINGLE BALLOON AND DOUBLE BALLOON SYSTEMS
27. USEFULNESS OF A NOVEL SMARTPHONE APP IN GASTROINTESTINAL ENDOSCOPY TO TRACK PROCEDURE NUMBERS AND THERAPEUTIC INTERVENTIONS
28. Mo1514: ULCERATIVE COLITIS DISEASE ACTIVITY IS DOMINATED BY INNATE IMMUNITY AND FEATURES OF TISSUE REMODELING
29. Tu1035: PREDICTING TRANSITION SUCCESS IN YOUNG ADULTS WITH INFLAMMATORY BOWEL DISEASE: RESULTS FROM A RETROSPECTIVE MEDICAL CHART REVIEW
30. Tu1251: INCIDENCE AND PREVALENCE OF PRIMARY SCLEROSING CHOLANGITIS: A META-ANALYSIS OF POPULATION-BASED STUDIES
31. Mo1915 A MULTICENTER, DOUBLE BLINDED, RANDOMIZED PILOT TRIAL COMPARING FECAL MICROBIOTA TRANSPLANTATION (FMT) TO PLACEBO AT INCUDING CLINICAL AND ENDOSCOPIC REMISSION IN MILD TO MODERATE CROHN'S DISEASE
32. Su1844 ASSESSING THE EFFECTIVENESS OF A REMOTE MONITORING PROTOCOL FOR ULCERATIVE COLITIS PATIENTS - ULCERATIVE COLITIS CLINICAL OUTREACH (UCCO)
33. Noninvasive Fecal Immunochemical Testing and Fecal Calprotectin Predict Mucosal Healing in Inflammatory Bowel Disease: A Prospective Cohort Study
34. The Impact of the COVID-19 Pandemic on IBD Care in Alberta: Patient and Provider Perspectives.
35. Defining Transition Success for Young Adults with Inflammatory Bowel Disease According to Patients, Parents and Health Care Providers
36. Canadian Consensus Statements on the Transition of Adolescents and Young Adults with Inflammatory Bowel Disease from Pediatric to Adult Care: A Collaborative Initiative Between the Canadian IBD Transition Network and Crohn’s and Colitis Canada
37. Additional file 1 of Multimodal intervention to improve the transition of patients with inflammatory bowel disease from pediatric to adult care: protocol for a randomized controlled trial
38. Double blind placebo-controlled trial for the prevention of ulcerative colitis relapses by β-fructan prebiotics: efficacy and metabolomic analysis
39. The Impact of the COVID-19 Pandemic on IBD Care in Alberta: Patient and Provider Perspectives
40. A Dedicated Pregnancy Clinic Improves Reproductive Knowledge in Inflammatory Bowel Disease
41. 608 PREBIOTIC β-FRUCTANS PREVENT SUBCLINICAL INTESTINAL INFLAMMATION IN ULCERATIVE COLITIS PATIENTS WHO ARE IN CLINICAL REMISSION
42. Fr099 HEALTHCARE PROVIDER SATISFACTION WITH VIRTUAL CARE DELIVERY IN ALBERTA DURING THE COVID-19 PANDEMIC.
43. Fr098 IMPACT OF COVID-19 PANDEMIC IN IBD PATIENT CARE
44. Inflammatory Bowel Disease: A Gastrointestinal Presentation of Congenital Plasminogen Deficiency
45. Mo1104 VIRTUAL MINDFULNESS-BASED STRESS REDUCTION FOR ADULTS WITH INFLAMMATROY BOWEL DISEASE: FEASIBILITY TRIAL RESULTS
46. Concomitant 5-Aminosalicylate Therapy in Moderate-to-Severe Ulcerative Colitis Patients Escalated to Infliximab Is Not Beneficial
47. Management of Inflammatory Bowel Disease Patients With Clinical Care Pathways Reduces Emergency Department Utilization
48. Training disrupted: Practical tips for supporting competency-based medical education during the COVID-19 pandemic
49. 279 COMBINATION THERAPY DOES NOT IMPROVE CLINICAL AND ENDOSCOPIC REMISSION RATES WITH VEDOLIZUMAB OR USTEKINUMAB IN CROHN'S DISEASE AND ULCERATIVE COLITIS
50. Sa1845 THE RISK OF ADVERSE PREGNANCY-RELATED OUTCOMES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A CANADIAN PROSPECTIVE STUDY
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.